PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
6.10%
Net income growth under 50% of MRVL's 39.60%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-1.69%
Both reduce yoy D&A, with MRVL at -12.08%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-5800.00%
Negative yoy deferred tax while MRVL stands at 27.27%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
7.69%
Less SBC growth vs. MRVL's 16.85%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
46.99%
Slight usage while MRVL is negative at -156.16%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
74.03%
AR growth is negative or stable vs. MRVL's 152.56%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
31.67%
Some inventory rise while MRVL is negative at -1291.11%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
68.52%
A yoy AP increase while MRVL is negative at -97.00%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-12.90%
Both reduce yoy usage, with MRVL at -162.25%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
471.43%
Some yoy increase while MRVL is negative at -616.73%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
34.65%
Some CFO growth while MRVL is negative at -33.25%. John Neff would note a short-term liquidity lead over the competitor.
-1.63%
Negative yoy CapEx while MRVL is 29.37%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-174.33%
Negative yoy purchasing while MRVL stands at 15.40%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
39.84%
Proceeds from sales/maturities above 1.5x MRVL's 4.27%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-11600.00%
We reduce yoy other investing while MRVL is 84.03%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-210.13%
We reduce yoy invests while MRVL stands at 178.71%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-79.27%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
2.39%
Buyback growth below 50% of MRVL's 97.38%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.